Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis
- PMID: 16420505
- DOI: 10.1111/j.1478-3231.2005.01192.x
Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis
Abstract
Hepatic fibrosis is the common wound-healing response to chronic liver injury. In this process, activation of hepatic stellate cells is characteristic of cell proliferation and migration, production of collagen and other extracellular matrix (ECM) molecules, and contraction after transforming into myofibroblasts. It has been shown that the fibrogenic process is prominently regulated by transforming growth factor-beta1 (TGF-beta1) and that the specific blockade of TGF-beta1/Smad3 signaling may therapeutically intervene the fibrosis of various tissues. In this review, we attempt to integrate recent advances in the understanding of the mechanisms underlying TGF-beta1/Smad3 pathway modulation of ECM gene expression in the context of liver fibrosis, discuss intervention strategies targeting the blockade of related signal pathways, and look into novel ways to the safe and efficacious prevention and treatment of hepatic fibrosis.
Similar articles
-
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):300-8. Hepatobiliary Pancreat Dis Int. 2009. PMID: 19502172
-
Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.Hepatology. 2003 May;37(5):1067-78. doi: 10.1053/jhep.2003.50196. Hepatology. 2003. PMID: 12717387
-
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.Liver Int. 2009 Aug;29(7):997-1009. doi: 10.1111/j.1478-3231.2009.02011.x. Epub 2009 Apr 28. Liver Int. 2009. PMID: 19422482
-
Cirrhosis--can we reverse hepatic fibrosis?Eur J Surg Suppl. 2002;(587):100-12. Eur J Surg Suppl. 2002. PMID: 16144208 Review.
-
Chronic liver injury, TGF-beta, and cancer.Exp Mol Med. 2001 Dec 31;33(4):179-90. doi: 10.1038/emm.2001.31. Exp Mol Med. 2001. PMID: 11795478 Review.
Cited by
-
Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl(4)-induced hepatic fibrosis in mice.Mol Ther. 2012 Nov;20(11):2043-51. doi: 10.1038/mt.2012.148. Epub 2012 Jul 31. Mol Ther. 2012. PMID: 22850680 Free PMC article.
-
Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1292-301. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973013 Free PMC article.
-
Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene.J Gene Med. 2009 Sep;11(9):764-71. doi: 10.1002/jgm.1357. J Gene Med. 2009. PMID: 19554613 Free PMC article.
-
Reduction of conjunctival fibrosis after trabeculectomy using topical α-lipoic acid in rabbit eyes.J Glaucoma. 2014 Aug;23(6):372-9. doi: 10.1097/IJG.0000000000000052. J Glaucoma. 2014. PMID: 25055213 Free PMC article.
-
Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models.Ann Transl Med. 2021 May;9(9):801. doi: 10.21037/atm-21-1884. Ann Transl Med. 2021. PMID: 34268414 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
